Can Milrinone Be a Therapeutic Alternative in Persistent Pulmonary Hypertension of the Newborn? A Case Series and Narrative Review

Background: Persistent pulmonary hypertension of the newborn (PPHN) remains a life-threatening condition resulting from failure of postnatal circulatory adaptation. Inhaled nitric oxide (iNO) is the standard first-line therapy; however, limited access or inadequate response highlight the need for al...

全面介紹

書目詳細資料

Principais autores:	Eliza Wasilewska, Norbert Dera, Łukasz Minarowski, Łukasz Osiński, Anna Doboszynska, Sławomir Szajda, Alina Minarowska
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2025-11-01
叢編:	Pediatric Reports
主題:	persistent pulmonary hypertension of the newborn PPHN milrinone inhaled nitric oxide neonatal pulmonary hypertension vasodilator therapy
在線閱讀:	https://www.mdpi.com/2036-7503/17/6/116
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!